{"transactions":[{"id":4633699,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-10-02T00:23:08.000Z","date":"2026-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":4086,"price":60,"value":245160.0,"ownership":{"direct":true},"balance_after":47732,"source":{"system":"sec-edgar","filing":"0001628280-26-064272","document":"wk-form4_1790886185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026064272/wk-form4_1790886185.xml","form_type":"4"}},{"id":4617475,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14834,"kind":"person","name":"Plenge Robert M","position":1,"cik":"0001773367","reported_name":"Plenge Robert M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-14T22:55:01.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":6140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on September 10, 2026. Price not applicable."}],"balance_after":6140,"source":{"system":"sec-edgar","filing":"0001628280-26-061940","document":"wk-form4_1789426499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1773367/000162828026061940/wk-form4_1789426499.xml","form_type":"4"}},{"id":3498,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:41:11.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":17557,"price":66.284,"value":1163748.188,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.271 to $66.39. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":61003,"source":{"system":"sec-edgar","filing":"0001628280-26-060572","document":"wk-form4_1788475269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380710/000162828026060572/wk-form4_1788475269.xml","form_type":"4"}},{"id":750015,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":36776,"kind":"person","name":"Countouriotis Athena","position":1,"cik":"0001571469","reported_name":"Countouriotis Athena","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:10:15.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":21040,"source":{"system":"sec-edgar","filing":"0001628280-26-040922","document":"wk-form4_1780611012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040922/wk-form4_1780611012.xml","form_type":"4"}},{"id":750014,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:09:04.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":17270,"source":{"system":"sec-edgar","filing":"0001628280-26-040920","document":"wk-form4_1780610941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040920/wk-form4_1780610941.xml","form_type":"4"}},{"id":750013,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35961,"kind":"person","name":"Ho Maykin","position":1,"cik":"0001646395","reported_name":"Ho Maykin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:07:53.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":35500,"source":{"system":"sec-edgar","filing":"0001628280-26-040918","document":"wk-form4_1780610870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040918/wk-form4_1780610870.xml","form_type":"4"}},{"id":750012,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":23696,"kind":"person","name":"HOMBACH ROBERT J.","position":1,"cik":"0001496182","reported_name":"HOMBACH ROBERT J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:06:33.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":49360,"source":{"system":"sec-edgar","filing":"0001628280-26-040916","document":"wk-form4_1780610790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040916/wk-form4_1780610790.xml","form_type":"4"}},{"id":750011,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":41447,"kind":"person","name":"Enyedy Mark J","position":1,"cik":"0001586965","reported_name":"Enyedy Mark J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:05:52.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":21040,"source":{"system":"sec-edgar","filing":"0001628280-26-040914","document":"wk-form4_1780610750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040914/wk-form4_1780610750.xml","form_type":"4"}},{"id":750010,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":13975,"kind":"person","name":"Dere Willard H","position":1,"cik":"0001311569","reported_name":"Dere Willard H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:04:30.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":46440,"source":{"system":"sec-edgar","filing":"0001628280-26-040911","document":"wk-form4_1780610668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040911/wk-form4_1780610668.xml","form_type":"4"}},{"id":750009,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":26178,"kind":"person","name":"CLARK IAN T","position":1,"cik":"0001336504","reported_name":"CLARK IAN T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:03:43.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":14490,"source":{"system":"sec-edgar","filing":"0001628280-26-040909","document":"wk-form4_1780610621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040909/wk-form4_1780610621.xml","form_type":"4"}},{"id":750008,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":41446,"kind":"person","name":"Bodem Barbara W.","position":1,"cik":"0001713893","reported_name":"Bodem Barbara W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:02:49.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":21045,"source":{"system":"sec-edgar","filing":"0001628280-26-040907","document":"wk-form4_1780610567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040907/wk-form4_1780610567.xml","form_type":"4"}},{"id":750007,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:01:37.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":41940,"source":{"system":"sec-edgar","filing":"0001628280-26-040903","document":"wk-form4_1780610493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040903/wk-form4_1780610493.xml","form_type":"4"}},{"id":768589,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-21T22:05:02.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2318,"price":50.2,"value":116363.6,"ownership":{"direct":true},"balance_after":42472,"source":{"system":"sec-edgar","filing":"0001628280-26-037455","document":"wk-form4_1779401100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026037455/wk-form4_1779401100.xml","form_type":"4"}},{"id":785327,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-05-11T21:01:13.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":3281,"price":53.85,"value":176681.85,"ownership":{"direct":true},"balance_after":51818,"source":{"system":"sec-edgar","filing":"0001628280-26-033639","document":"wk-form4_1778533271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026033639/wk-form4_1778533271.xml","form_type":"4"}},{"id":833872,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:53:12.000Z","date":"2026-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1273,"price":56.05,"value":71351.65,"ownership":{"direct":true},"balance_after":78560,"source":{"system":"sec-edgar","filing":"0001628280-26-019862","document":"wk-form4_1773953589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019862/wk-form4_1773953589.xml","form_type":"4"}},{"id":833871,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:50:54.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1693,"price":56.05,"value":94892.65,"ownership":{"direct":true},"balance_after":84140,"source":{"system":"sec-edgar","filing":"0001628280-26-019857","document":"wk-form4_1773953452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019857/wk-form4_1773953452.xml","form_type":"4"}},{"id":833869,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:48:04.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2117,"price":56.05,"value":118657.85,"ownership":{"direct":true},"balance_after":123314,"source":{"system":"sec-edgar","filing":"0001628280-26-019853","document":"wk-form4_1773953282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019853/wk-form4_1773953282.xml","form_type":"4"}},{"id":833870,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:34:31.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4252,"price":56.05,"value":238324.6,"ownership":{"direct":true},"balance_after":214635,"source":{"system":"sec-edgar","filing":"0001628280-26-019847","document":"wk-form4_1773952468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019847/wk-form4_1773952468.xml","form_type":"4"}},{"id":835673,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T17:42:15.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":36680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":36680,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":36680},"source":{"system":"sec-edgar","filing":"0001628280-26-019269","document":"wk-form4_1773855732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019269/wk-form4_1773855732.xml","form_type":"4"}},{"id":835672,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:42:15.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1245,"price":56.05,"value":69782.25,"ownership":{"direct":true},"balance_after":44790,"source":{"system":"sec-edgar","filing":"0001628280-26-019269","document":"wk-form4_1773855732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019269/wk-form4_1773855732.xml","form_type":"4"}},{"id":835671,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:42:15.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":15410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."}],"balance_after":46035,"source":{"system":"sec-edgar","filing":"0001628280-26-019269","document":"wk-form4_1773855732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019269/wk-form4_1773855732.xml","form_type":"4"}},{"id":835669,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T17:39:42.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":45600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":45600,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":45600},"source":{"system":"sec-edgar","filing":"0001628280-26-019266","document":"wk-form4_1773855579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019266/wk-form4_1773855579.xml","form_type":"4"}},{"id":835668,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:39:42.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1629,"price":56.05,"value":91305.45,"ownership":{"direct":true},"balance_after":55099,"source":{"system":"sec-edgar","filing":"0001628280-26-019266","document":"wk-form4_1773855579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019266/wk-form4_1773855579.xml","form_type":"4"}},{"id":835667,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:39:42.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":19150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."}],"balance_after":56728,"source":{"system":"sec-edgar","filing":"0001628280-26-019266","document":"wk-form4_1773855579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019266/wk-form4_1773855579.xml","form_type":"4"}},{"id":839165,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T00:50:38.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":35680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":35680,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":35680},"source":{"system":"sec-edgar","filing":"0001628280-26-019012","document":"wk-form4_1773795035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019012/wk-form4_1773795035.xml","form_type":"4"}},{"id":839164,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:50:38.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":14990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by one share to correct a previous clerical error."}],"balance_after":85833,"source":{"system":"sec-edgar","filing":"0001628280-26-019012","document":"wk-form4_1773795035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019012/wk-form4_1773795035.xml","form_type":"4"}},{"id":839163,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:50:38.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":9109,"price":58.51,"value":532967.59,"ownership":{"direct":true},"balance_after":70843,"source":{"system":"sec-edgar","filing":"0001628280-26-019012","document":"wk-form4_1773795035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019012/wk-form4_1773795035.xml","form_type":"4"}},{"id":839168,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T00:48:08.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":34690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":34690,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-17","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":34690},"source":{"system":"sec-edgar","filing":"0001628280-26-019010","document":"wk-form4_1773794885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019010/wk-form4_1773794885.xml","form_type":"4"}},{"id":839167,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:48:08.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":14570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by thirteen shares to correct a previous clerical error."}],"balance_after":79833,"source":{"system":"sec-edgar","filing":"0001628280-26-019010","document":"wk-form4_1773794885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019010/wk-form4_1773794885.xml","form_type":"4"}},{"id":839166,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:48:08.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7177,"price":58.51,"value":419926.27,"ownership":{"direct":true},"balance_after":65263,"source":{"system":"sec-edgar","filing":"0001628280-26-019010","document":"wk-form4_1773794885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019010/wk-form4_1773794885.xml","form_type":"4"}},{"id":839162,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T00:45:54.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":44600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":44600,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":44600},"source":{"system":"sec-edgar","filing":"0001628280-26-019008","document":"wk-form4_1773794751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019008/wk-form4_1773794751.xml","form_type":"4"}},{"id":839161,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:45:54.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":18740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by two shares to correct a previous clerical error."}],"balance_after":125431,"source":{"system":"sec-edgar","filing":"0001628280-26-019008","document":"wk-form4_1773794751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019008/wk-form4_1773794751.xml","form_type":"4"}},{"id":839160,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:45:54.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":9945,"price":58.51,"value":581881.95,"ownership":{"direct":true},"balance_after":106691,"source":{"system":"sec-edgar","filing":"0001628280-26-019008","document":"wk-form4_1773794751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019008/wk-form4_1773794751.xml","form_type":"4"}},{"id":839159,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T00:43:06.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":89200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":89200,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":89200},"source":{"system":"sec-edgar","filing":"0001628280-26-019006","document":"wk-form4_1773794583.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019006/wk-form4_1773794583.xml","form_type":"4"}},{"id":839158,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:43:06.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":62440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."}],"balance_after":218887,"source":{"system":"sec-edgar","filing":"0001628280-26-019006","document":"wk-form4_1773794583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019006/wk-form4_1773794583.xml","form_type":"4"}},{"id":839157,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:43:06.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2941,"price":58.51,"value":172077.91,"ownership":{"direct":true},"balance_after":156447,"source":{"system":"sec-edgar","filing":"0001628280-26-019006","document":"wk-form4_1773794583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019006/wk-form4_1773794583.xml","form_type":"4"}},{"id":846880,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-12T23:55:45.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":16486,"price":60.46,"value":996743.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $60.39 to $60.62. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price"}],"balance_after":79953,"source":{"system":"sec-edgar","filing":"0001628280-26-017447","document":"wk-form4_1773359742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026017447/wk-form4_1773359742.xml","form_type":"4"}},{"id":880228,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:49:52.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":2371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":96439,"source":{"system":"sec-edgar","filing":"0001628280-26-012542","document":"wk-form4_1772156989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012542/wk-form4_1772156989.xml","form_type":"4"}},{"id":880227,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:49:52.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":94068,"source":{"system":"sec-edgar","filing":"0001628280-26-012542","document":"wk-form4_1772156989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012542/wk-form4_1772156989.xml","form_type":"4"}},{"id":880226,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:49:52.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":87393,"source":{"system":"sec-edgar","filing":"0001628280-26-012542","document":"wk-form4_1772156989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012542/wk-form4_1772156989.xml","form_type":"4"}},{"id":880225,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:39:05.000Z","date":"2026-02-26","kind":"sale","planned":false,"acquired":false,"shares":6326,"price":60.3758,"value":381937.3108,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $60.36 to $60.51. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price"}],"balance_after":37578,"source":{"system":"sec-edgar","filing":"0001628280-26-012539","document":"wk-form4_1772156343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012539/wk-form4_1772156343.xml","form_type":"4"}},{"id":880224,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-26","kind":"sale","planned":false,"acquired":false,"shares":26061,"price":61.36,"value":1599102.96,"ownership":{"direct":true},"balance_after":72453,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":880223,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":2372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":98514,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":880222,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":96142,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":880221,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":89467,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":880212,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:28:58.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":2569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":116638,"source":{"system":"sec-edgar","filing":"0001628280-26-012529","document":"wk-form4_1772155735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012529/wk-form4_1772155735.xml","form_type":"4"}},{"id":880211,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:28:58.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":7230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":114069,"source":{"system":"sec-edgar","filing":"0001628280-26-012529","document":"wk-form4_1772155735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012529/wk-form4_1772155735.xml","form_type":"4"}},{"id":880210,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:28:58.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":106839,"source":{"system":"sec-edgar","filing":"0001628280-26-012529","document":"wk-form4_1772155735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012529/wk-form4_1772155735.xml","form_type":"4"}},{"id":905773,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:01:49.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":375,"price":54.137,"value":20301.375,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":100156,"source":{"system":"sec-edgar","filing":"0001628280-26-008254","document":"wk-form5_1771027306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008254/wk-form5_1771027306.xml","form_type":"5"}},{"id":905772,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-14T00:00:05.000Z","date":"2025-12-30","kind":"gift","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":126926,"source":{"system":"sec-edgar","filing":"0001628280-26-008241","document":"wk-form5_1771027202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008241/wk-form5_1771027202.xml","form_type":"5"}},{"id":905771,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:58:22.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":80,"price":45.535,"value":3642.8,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":30625,"source":{"system":"sec-edgar","filing":"0001628280-26-008231","document":"wk-form5_1771027100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008231/wk-form5_1771027100.xml","form_type":"5"}},{"id":905770,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:56:35.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":62,"price":45.535,"value":2823.17,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":81217,"source":{"system":"sec-edgar","filing":"0001628280-26-008221","document":"wk-form5_1771026992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008221/wk-form5_1771026992.xml","form_type":"5"}},{"id":905769,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:56:35.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":317,"price":54.137,"value":17161.429,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":81155,"source":{"system":"sec-edgar","filing":"0001628280-26-008221","document":"wk-form5_1771026992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008221/wk-form5_1771026992.xml","form_type":"5"}},{"id":905768,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:54:26.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":398,"price":45.535,"value":18122.93,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":43904,"source":{"system":"sec-edgar","filing":"0001628280-26-008218","document":"wk-form5_1771026863.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008218/wk-form5_1771026863.xml","form_type":"5"}},{"id":905767,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:52:06.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":375,"price":54.137,"value":20301.375,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":83290,"source":{"system":"sec-edgar","filing":"0001628280-26-008216","document":"wk-form5_1771026723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008216/wk-form5_1771026723.xml","form_type":"5"}},{"id":933648,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":69020,"kind":"person","name":"Ramchandani Rashmi Virendra","position":1,"cik":"0002106034","reported_name":"Ramchandani Rashmi Virendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-01-22T23:12:07.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":18220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on January 20, 2027 and 1/48th on the 20th day of each month thereafter."}],"balance_after":18220,"derivative":{"exercise_price":56.31,"exercise_date":"2027-01-20","expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":18220},"source":{"system":"sec-edgar","filing":"0001628280-26-003139","document":"wk-form4_1769123524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026003139/wk-form4_1769123524.xml","form_type":"4"}},{"id":933647,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":69020,"kind":"person","name":"Ramchandani Rashmi Virendra","position":1,"cik":"0002106034","reported_name":"Ramchandani Rashmi Virendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-22T23:12:07.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":7070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on January 20, 2026. Price not applicable."}],"balance_after":25610,"source":{"system":"sec-edgar","filing":"0001628280-26-003139","document":"wk-form4_1769123524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026003139/wk-form4_1769123524.xml","form_type":"4"}},{"id":933646,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":69020,"kind":"person","name":"Ramchandani Rashmi Virendra","position":1,"cik":"0002106034","reported_name":"Ramchandani Rashmi Virendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-22T23:12:07.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":18540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on January 20, 2026. Price not applicable."}],"balance_after":18540,"source":{"system":"sec-edgar","filing":"0001628280-26-003139","document":"wk-form4_1769123524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026003139/wk-form4_1769123524.xml","form_type":"4"}},{"id":984090,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-02T23:29:07.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":16570,"price":55.03,"value":911847.1,"ownership":{"direct":true},"balance_after":159388,"source":{"system":"sec-edgar","filing":"0001628280-25-054856","document":"wk-form4_1764718145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828025054856/wk-form4_1764718145.xml","form_type":"4"}},{"id":984089,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-02T23:29:07.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":375,"price":54.137,"value":20301.375,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":175958,"source":{"system":"sec-edgar","filing":"0001628280-25-054856","document":"wk-form4_1764718145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828025054856/wk-form4_1764718145.xml","form_type":"4"}},{"id":1027941,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2025-10-02T20:33:15.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3304,"price":54.16,"value":178944.64,"ownership":{"direct":true},"balance_after":43506,"source":{"system":"sec-edgar","filing":"0002038768-25-000007","document":"wk-form4_1759437191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000203876825000007/wk-form4_1759437191.xml","form_type":"4"}},{"id":1075187,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":26178,"kind":"person","name":"CLARK IAN T","position":1,"cik":"0001336504","reported_name":"CLARK IAN T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T22:55:48.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on August 1, 2025. Price not applicable."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001048477-25-000095","document":"wk-form4_1754434545.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000095/wk-form4_1754434545.xml","form_type":"4"}},{"id":1137828,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:02:57.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2155,"price":59.93,"value":129149.15,"ownership":{"direct":true},"balance_after":30545,"source":{"system":"sec-edgar","filing":"0001048477-25-000080","document":"wk-form4_1747947769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000080/wk-form4_1747947769.xml","form_type":"4"}},{"id":1137826,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:01:26.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":9780,"source":{"system":"sec-edgar","filing":"0001048477-25-000078","document":"wk-form4_1747947678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000078/wk-form4_1747947678.xml","form_type":"4"}},{"id":1137827,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":66558,"kind":"person","name":"MEIER RICHARD A","position":1,"cik":"0001227305","reported_name":"MEIER RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:00:00.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":127426,"source":{"system":"sec-edgar","filing":"0001048477-25-000076","document":"wk-form4_1747947594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000076/wk-form4_1747947594.xml","form_type":"4"}},{"id":1137825,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":23696,"kind":"person","name":"HOMBACH ROBERT J.","position":1,"cik":"0001496182","reported_name":"HOMBACH ROBERT J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:58:40.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":41870,"source":{"system":"sec-edgar","filing":"0001048477-25-000074","document":"wk-form4_1747947514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000074/wk-form4_1747947514.xml","form_type":"4"}},{"id":1137824,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35961,"kind":"person","name":"Ho Maykin","position":1,"cik":"0001646395","reported_name":"Ho Maykin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:57:38.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":28010,"source":{"system":"sec-edgar","filing":"0001048477-25-000072","document":"wk-form4_1747947452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000072/wk-form4_1747947452.xml","form_type":"4"}},{"id":1137823,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":41447,"kind":"person","name":"Enyedy Mark J","position":1,"cik":"0001586965","reported_name":"Enyedy Mark J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:56:05.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":13550,"source":{"system":"sec-edgar","filing":"0001048477-25-000070","document":"wk-form4_1747947358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000070/wk-form4_1747947358.xml","form_type":"4"}},{"id":1137822,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":13975,"kind":"person","name":"Dere Willard H","position":1,"cik":"0001311569","reported_name":"Dere Willard H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:54:23.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":38950,"source":{"system":"sec-edgar","filing":"0001048477-25-000068","document":"wk-form4_1747947254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000068/wk-form4_1747947254.xml","form_type":"4"}},{"id":1137821,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":36776,"kind":"person","name":"Countouriotis Athena","position":1,"cik":"0001571469","reported_name":"Countouriotis Athena","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:52:41.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":13550,"source":{"system":"sec-edgar","filing":"0001048477-25-000066","document":"wk-form4_1747947154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000066/wk-form4_1747947154.xml","form_type":"4"}},{"id":1137820,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":41446,"kind":"person","name":"Bodem Barbara W.","position":1,"cik":"0001713893","reported_name":"Bodem Barbara W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:51:20.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by five shares to correct a previous clerical error."}],"balance_after":13555,"source":{"system":"sec-edgar","filing":"0001048477-25-000064","document":"wk-form4_1747947072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000064/wk-form4_1747947072.xml","form_type":"4"}},{"id":1137819,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":35893,"kind":"person","name":"ANDERSON ELIZABETH M","position":1,"cik":"0001758247","reported_name":"ANDERSON ELIZABETH M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:49:40.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":34450,"source":{"system":"sec-edgar","filing":"0001048477-25-000062","document":"wk-form4_1747946974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000062/wk-form4_1747946974.xml","form_type":"4"}},{"id":1140904,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:58:27.000Z","date":"2025-05-20","kind":"sale","planned":true,"acquired":false,"shares":1786,"price":59.31,"value":105927.66,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 26, 2024."}],"balance_after":14173,"source":{"system":"sec-edgar","filing":"0001048477-25-000060","document":"wk-form4_1747778300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000060/wk-form4_1747778300.xml","form_type":"4"}},{"id":1140903,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:58:27.000Z","date":"2025-05-19","kind":"tax_withholding","planned":true,"acquired":false,"shares":996,"price":59.27,"value":59032.92,"ownership":{"direct":true},"balance_after":15959,"source":{"system":"sec-edgar","filing":"0001048477-25-000060","document":"wk-form4_1747778300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000060/wk-form4_1747778300.xml","form_type":"4"}},{"id":1157718,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-06T21:07:22.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":273,"price":64.92,"value":17723.16,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2024."}],"balance_after":32700,"source":{"system":"sec-edgar","filing":"0001048477-25-000053","document":"wk-form4_1746565636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000053/wk-form4_1746565636.xml","form_type":"4"}},{"id":1157717,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-06T21:07:22.000Z","date":"2025-04-30","kind":"grant","planned":true,"acquired":true,"shares":273,"price":54.137,"value":14779.401,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":32973,"source":{"system":"sec-edgar","filing":"0001048477-25-000053","document":"wk-form4_1746565636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000053/wk-form4_1746565636.xml","form_type":"4"}},{"id":1196017,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-20T23:38:48.000Z","date":"2025-03-19","kind":"sale","planned":true,"acquired":false,"shares":1295,"price":71.52,"value":92618.4,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 26, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by two shares to correct a previous clerical error."}],"balance_after":16955,"source":{"system":"sec-edgar","filing":"0001048477-25-000041","document":"wk-form4_1742513921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000041/wk-form4_1742513921.xml","form_type":"4"}},{"id":1201352,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T23:53:01.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":9230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":9230,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":9230},"source":{"system":"sec-edgar","filing":"0001048477-25-000039","document":"wk-form4_1742341974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000039/wk-form4_1742341974.xml","form_type":"4"}},{"id":1201351,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:53:01.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":5970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":18252,"source":{"system":"sec-edgar","filing":"0001048477-25-000039","document":"wk-form4_1742341974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000039/wk-form4_1742341974.xml","form_type":"4"}},{"id":1201350,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:53:01.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":823,"price":69.44,"value":57149.12,"ownership":{"direct":true},"balance_after":12282,"source":{"system":"sec-edgar","filing":"0001048477-25-000039","document":"wk-form4_1742341974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000039/wk-form4_1742341974.xml","form_type":"4"}},{"id":1201349,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T23:51:12.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":30020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":30020,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":30020},"source":{"system":"sec-edgar","filing":"0001048477-25-000037","document":"wk-form4_1742341865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000037/wk-form4_1742341865.xml","form_type":"4"}},{"id":1201348,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:51:12.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":12940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":82915,"source":{"system":"sec-edgar","filing":"0001048477-25-000037","document":"wk-form4_1742341865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000037/wk-form4_1742341865.xml","form_type":"4"}},{"id":1201347,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:51:12.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":16249,"price":69.44,"value":1128330.56,"ownership":{"direct":true},"balance_after":69975,"source":{"system":"sec-edgar","filing":"0001048477-25-000037","document":"wk-form4_1742341865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000037/wk-form4_1742341865.xml","form_type":"4"}},{"id":1201346,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:25:52.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":30880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":30880,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":30880},"source":{"system":"sec-edgar","filing":"0001048477-25-000035","document":"wk-form4_1742336744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000035/wk-form4_1742336744.xml","form_type":"4"}},{"id":1201345,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:25:52.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":13310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":32700,"source":{"system":"sec-edgar","filing":"0001048477-25-000035","document":"wk-form4_1742336744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000035/wk-form4_1742336744.xml","form_type":"4"}},{"id":1201344,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:23:32.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":41170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":41170,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":41170},"source":{"system":"sec-edgar","filing":"0001048477-25-000033","document":"wk-form4_1742336605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000033/wk-form4_1742336605.xml","form_type":"4"}},{"id":1201343,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":48434,"kind":"person","name":"Friberg Gregory R","position":1,"cik":"0002038768","reported_name":"Friberg Gregory R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief R&D Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:23:32.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":17750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":46810,"source":{"system":"sec-edgar","filing":"0001048477-25-000033","document":"wk-form4_1742336605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000033/wk-form4_1742336605.xml","form_type":"4"}},{"id":1201342,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:22:00.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":30880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":30880,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":30880},"source":{"system":"sec-edgar","filing":"0001048477-25-000031","document":"wk-form4_1742336512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000031/wk-form4_1742336512.xml","form_type":"4"}},{"id":1201341,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:22:00.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":13310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":80838,"source":{"system":"sec-edgar","filing":"0001048477-25-000031","document":"wk-form4_1742336512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000031/wk-form4_1742336512.xml","form_type":"4"}},{"id":1201340,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:22:00.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":20127,"price":69.44,"value":1397618.88,"ownership":{"direct":true},"balance_after":67528,"source":{"system":"sec-edgar","filing":"0001048477-25-000031","document":"wk-form4_1742336512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000031/wk-form4_1742336512.xml","form_type":"4"}},{"id":1201339,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:19:33.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":38590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":38590,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":38590},"source":{"system":"sec-edgar","filing":"0001048477-25-000029","document":"wk-form4_1742336367.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000029/wk-form4_1742336367.xml","form_type":"4"}},{"id":1201338,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:19:33.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":16640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":99781,"source":{"system":"sec-edgar","filing":"0001048477-25-000029","document":"wk-form4_1742336367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000029/wk-form4_1742336367.xml","form_type":"4"}},{"id":1201337,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:19:33.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":18497,"price":69.44,"value":1284431.68,"ownership":{"direct":true},"balance_after":83141,"source":{"system":"sec-edgar","filing":"0001048477-25-000029","document":"wk-form4_1742336367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000029/wk-form4_1742336367.xml","form_type":"4"}},{"id":1201336,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:17:35.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":61750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":61750,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":61750},"source":{"system":"sec-edgar","filing":"0001048477-25-000027","document":"wk-form4_1742336248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000027/wk-form4_1742336248.xml","form_type":"4"}},{"id":1201335,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:17:35.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":44360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":175583,"source":{"system":"sec-edgar","filing":"0001048477-25-000027","document":"wk-form4_1742336248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000027/wk-form4_1742336248.xml","form_type":"4"}},{"id":1201334,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:17:35.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2933,"price":69.44,"value":203667.52,"ownership":{"direct":true},"balance_after":131223,"source":{"system":"sec-edgar","filing":"0001048477-25-000027","document":"wk-form4_1742336248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000027/wk-form4_1742336248.xml","form_type":"4"}},{"id":1218104,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-03-07T21:06:24.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":7034,"price":71.276,"value":501355.384,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The price actually received ranged from $71.276 to $71.285. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":87655,"source":{"system":"sec-edgar","filing":"0001048477-25-000025","document":"wk-form4_1741381578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000025/wk-form4_1741381578.xml","form_type":"4"}},{"id":1231045,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57237,"kind":"person","name":"Guyer Charles Greg","position":1,"cik":"0001811096","reported_name":"Guyer Charles Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-03-04T21:11:20.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":4287,"price":71.16,"value":305062.92,"ownership":{"direct":true},"balance_after":94689,"source":{"system":"sec-edgar","filing":"0001048477-25-000021","document":"wk-form4_1741122664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000021/wk-form4_1741122664.xml","form_type":"4"}},{"id":1241458,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:19:58.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":9367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":101638,"source":{"system":"sec-edgar","filing":"0001048477-25-000019","document":"wk-form4_1740701992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000019/wk-form4_1740701992.xml","form_type":"4"}},{"id":1241457,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57235,"kind":"person","name":"Mueller Brian","position":1,"cik":"0001514980","reported_name":"Mueller Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:19:58.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":9660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2025, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":92271,"source":{"system":"sec-edgar","filing":"0001048477-25-000019","document":"wk-form4_1740701992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000019/wk-form4_1740701992.xml","form_type":"4"}}],"next_cursor":"2025-02-28T00:19:58.000000Z,1241457"}